These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33761887)

  • 21. Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study.
    Iaffaldano P; Lucisano G; Manni A; Paolicelli D; Patti F; Capobianco M; Brescia Morra V; Sola P; Pesci I; Lus G; De Luca G; Lugaresi A; Cavalla P; Montepietra S; Maniscalco GT; Granella F; Ragonese P; Vianello M; Brambilla L; Totaro R; Toscano S; Malucchi S; Petracca M; Moiola L; Ferraro D; Lepore V; Mosconi P; Ponzio M; Tedeschi G; Comi G; Battaglia MA; Filippi M; Amato MP; Trojano M;
    Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35046084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform.
    Jokubaitis VG; Spelman T; Lechner-Scott J; Barnett M; Shaw C; Vucic S; Liew D; Butzkueven H; Slee M;
    PLoS One; 2013; 8(3):e59694. PubMed ID: 23527252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of disease-modifying treatments discontinuation in patients with relapsing-remitting multiple sclerosis: A 5 year prospective cohort study.
    Bawand R; Ghiasian M; Fathoallahi N; Moradi A
    Mult Scler Relat Disord; 2022 Jul; 63():103857. PubMed ID: 35597079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using the extended self-regulatory model to characterise diabetes medication adherence: a cross-sectional study.
    Shiyanbola OO; Unni E; Huang YM; Lanier C
    BMJ Open; 2018 Nov; 8(11):e022803. PubMed ID: 30478112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease-modifying treatment, long-term outcomes and transition to progressive multiple sclerosis: data based on the New York State MS Consortium.
    Jakimovski D; Kavak KS; Coyle PK; Goodman AD; Gottesman M; Zivadinov R; Weinstock-Guttman B;
    J Neurol; 2024 Feb; 271(2):711-722. PubMed ID: 37995009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study.
    McKay KA; Tremlett H; Patten SB; Fisk JD; Evans C; Fiest K; Campbell T; Marrie RA;
    Mult Scler; 2017 Apr; 23(4):588-596. PubMed ID: 27357507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication beliefs in first-line and second-line treated multiple sclerosis patients.
    Pust GEA; Untiedt B; Weierstall-Pust R; Randerath J; Barabasch A; Rahn AC; Heesen C
    Mult Scler Relat Disord; 2020 Jul; 42():102144. PubMed ID: 32428775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of persistence with therapy on inpatient admissions and emergency room visits in the US among patients with multiple sclerosis.
    Thomas NP; Curkendall S; Farr AM; Yu E; Hurley D
    J Med Econ; 2016; 19(5):497-505. PubMed ID: 26706292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychometric evaluation of the 5-item Medication Adherence Report Scale questionnaire in persons with multiple sclerosis.
    Jožef M; Locatelli I; Brecl Jakob G; Savšek L; Šurlan Popovič K; Špiclin Ž; Rot U; Kos M
    PLoS One; 2024; 19(3):e0294116. PubMed ID: 38437197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medication adherence in a sample of elderly suffering from hypertension: evaluating the influence of illness perceptions, treatment beliefs, and illness burden.
    Rajpura J; Nayak R
    J Manag Care Pharm; 2014 Jan; 20(1):58-65. PubMed ID: 24511766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discontinuing Treatment Against Medical Advice: The Role of Perceived Autonomy Support From Providers in Relapsing-Remitting Multiple Sclerosis.
    Glusman M; Bruce A; Thelen J; Smith J; Lynch S; Catley D; Bennett KK; Bruce J
    Ann Behav Med; 2019 Mar; 53(3):283-289. PubMed ID: 29771271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medication adherence/persistence among patients with active multiple sclerosis in Finland.
    Lahdenperä S; Soilu-Hänninen M; Kuusisto HM; Atula S; Junnila J; Berglund A
    Acta Neurol Scand; 2020 Dec; 142(6):605-612. PubMed ID: 32559310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-reported outcomes in patients with relapsing forms of MS switching to teriflunomide from other disease-modifying therapies: Results from the global Phase 4 Teri-PRO study in routine clinical practice.
    Coyle PK; Khatri B; Edwards KR; Meca-Lallana JE; Cavalier S; Rufi P; Benamor M; Thangavelu K; Robinson M; Gold R;
    Mult Scler Relat Disord; 2018 Nov; 26():211-218. PubMed ID: 30273841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient-reported outcomes based on discontinuation or continuous treatment with natalizumab: New York State Multiple Sclerosis Consortium (NYSMSC) study.
    Jakimovski D; Kavak KS; Zakalik K; McGraw C; Gottesman M; Coyle PK; Zivadinov R; Weinstock-Guttman B;
    J Neurol Sci; 2023 Dec; 455():122781. PubMed ID: 37979415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication adherence with disease modifying treatments for multiple sclerosis among US employees.
    Kleinman NL; Beren IA; Rajagopalan K; Brook RA
    J Med Econ; 2010; 13(4):633-40. PubMed ID: 20958113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trajectories of disease-modifying therapies and associated sickness absence and disability pension among 1923 people with multiple sclerosis in Sweden.
    Teni FS; Machado A; Murley C; He A; Fink K; Gyllensten H; Glaser A; Alexanderson K; Hillert J; Friberg E
    Mult Scler Relat Disord; 2023 Jan; 69():104456. PubMed ID: 36529068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of goal cognitions, illness perceptions and treatment beliefs in self-reported adherence after kidney transplantation: a cohort study.
    Massey EK; Tielen M; Laging M; Beck DK; Khemai R; van Gelder T; Weimar W
    J Psychosom Res; 2013 Sep; 75(3):229-34. PubMed ID: 23972411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to glaucoma medication, illness perceptions, and beliefs about glaucoma: Attitudinal perspectives among Turkish population.
    Guven S; Koylu MT; Mumcuoglu T
    Eur J Ophthalmol; 2021 Mar; 31(2):469-476. PubMed ID: 32019338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-management behaviors in World Trade Center rescue and recovery workers with asthma.
    Rojano B; West E; Goodman E; Weiss JJ; de la Hoz RE; Crane M; Crowley L; Harrison D; Markowitz S; Wisnivesky JP
    J Asthma; 2019 Apr; 56(4):411-421. PubMed ID: 29985718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exacerbation history is associated with medication and appointment adherence in MS.
    Hancock LM; Bruce JM; Lynch SG
    J Behav Med; 2011 Oct; 34(5):330-8. PubMed ID: 21259038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.